Some digital hypertension solutions produce meaningful clinical and economic outcomes, while others fall short, according to a new report from Peterson Health Technology Institute.
Executives from Imagine360, Verily, BrightInsight, Lantern, and Rhapsody shared their approaches to reducing healthcare costs and facilitating digital transformation.
Hear executives from Quantum Health, Surescripts, EY, Clinical Architecture and Personify Health share their views on digital transformation in healthcare.
Novo Holdings led the Series A investment in Kivu Bioscience, developer of next-generation antibody drug conjugates for solid tumors. The startup's ADCs and technology were licensed from Synaffix, a Lonza subsidiary.
In this month's episode, Senior Reporter Katie Adams discussed some of the executive moves, exits and layoffs that recently occurred in the healthcare world. She also interviewed Amy Abernethy, who recently co-founded Highlander Health with fellow healthcare veteran Brad Hirsch.
Sponsored by Personify Health, a leader in personalized health platforms, the webinar draws attention to a variety of perspectives, including a CFO, a former CHRO, a chief medical officer and a health benefits research director.
A strategic orientation that leans into emerging value, even when this challenges our assumptions about who we are and what we do and the niche we do it in, enables organizations to make distinctive contributions sought by others.
For those who rely on these treatments, affordable medication access is a matter of health, freedom, and dignity, and their mechanisms and outcomes are non-partisan.
The shifting AI landscape. Learn about the emerging technologies from AI tech developers across the healthcare landscape from health tech startups to healthcare organizations, biopharma companies, and a medtech giant.
No comments:
Post a Comment